Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jill Waalen

    TitleAssociate Clinical Professor -
    SchoolUniversity of California, San Diego
    DepartmentFamily Medicine and Public Health
    Address9500 Gilman Drive #0811
    CA La Jolla 92093
    Phone858-534-9550
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Criqui MH, Knox JB, Denenberg JO, Forbang NI, McClelland RL, Novotny TE, Sandfort V, Waalen J, Blaha MJ, Allison MA. Coronary Artery Calcium Volume and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2017 Aug; 10(8):845-854. PMID: 28797404.
        View in: PubMed
      2. Waldram J, Walters K, Simon R, Woessner K, Waalen J, White A. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study. J Allergy Clin Immunol. 2017 May 25. PMID: 28550988.
        View in: PubMed
      3. Cook KA, Ford CM, Leyvas EA, Waalen J, White AA. Half of systemic reactions to allergen immunotherapy are delayed, majority require treatment with epinephrine. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1415-1417. PMID: 28454684.
        View in: PubMed
      4. Tsai BT, Dahms EB, Waalen J, Kimura BJ. Actual use of pocket-sized ultrasound devices for cardiovascular examination by trained physicians during a hospitalist rotation. J Community Hosp Intern Med Perspect. 2016; 6(6):33358. PMID: 27987287.
        View in: PubMed
      5. Sliman S, Waalen J, Shaw D. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence. Cardiovasc Toxicol. 2016 Oct; 16(4):381-9. PMID: 26661075.
        View in: PubMed
      6. Kimura BJ, Sliman SM, Waalen J, Amundson SA, Shaw DJ. Retention of Ultrasound Skills and Training in "Point-of-Care" Cardiac Ultrasound. J Am Soc Echocardiogr. 2016 Oct; 29(10):992-997. PMID: 27372559.
        View in: PubMed
      7. Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes. Am J Transplant. 2016 Jul; 16(7):1982-98. PMID: 26990570.
        View in: PubMed
      8. Reed GW, Cannon CP, Waalen J, Teirstein PS, Tanguay JF, Berger PB, Angiolillo DJ, Price MJ. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):190-198. PMID: 26909669.
        View in: PubMed
      9. Steinhubl SR, Mehta RR, Ebner GS, Ballesteros MM, Waalen J, Steinberg G, Van Crocker P, Felicione E, Carter CT, Edmonds S, Honcz JP, Miralles GD, Talantov D, Sarich TC, Topol EJ. Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial. Am Heart J. 2016 May; 175:77-85. PMID: 27179726.
        View in: PubMed
      10. Jones KD, Gelbart T, Whisenant TC, Waalen J, Mondala TS, Iklé DN, Salomon DR, Bennett RM, Kurian SM. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clin Exp Rheumatol. 2016 Mar-Apr; 34(2 Suppl 96):S89-98. PMID: 27157394; PMCID: PMC4888802.
      11. Hill LL, Nichols J, Wing D, Waalen J, Friedman E. Training on Exercise is Medicine® Within an Integrative Medicine Curriculum. Am J Prev Med. 2015 Nov; 49(5 Suppl 3):S278-84. PMID: 26477904.
        View in: PubMed
      12. Boeldt DL, Wineinger NE, Waalen J, Gollamudi S, Grossberg A, Steinhubl SR, McCollister-Slipp A, Rogers MA, Silvers C, Topol EJ. How Consumers and Physicians View New Medical Technology: Comparative Survey. J Med Internet Res. 2015 Sep 14; 17(9):e215. PMID: 26369254; PMCID: PMC4642377.
      13. Dunn AC, Black CL, Arnold J, Brodine S, Waalen J, Binkin N. Childhood vaccination coverage rates among military dependents in the United States. Pediatrics. 2015 May; 135(5):e1148-56. PMID: 25869378.
        View in: PubMed
      14. Waalen J. The genetics of human obesity. Transl Res. 2014 Oct; 164(4):293-301. PMID: 24929207.
        View in: PubMed
      15. Bennett RJ, Brodine S, Waalen J, Moser K, Rodwell TC. Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in San Diego County, January 2010-October 2012. Am J Public Health. 2014 Apr; 104(4):e95-e102. PMID: 24524534; PMCID: PMC4025726.
      16. Zhang K, Huentelman MJ, Rao F, Sun EI, Corneveaux JJ, Schork AJ, Wei Z, Waalen J, Miramontes-Gonzalez JP, Hightower CM, Maihofer AX, Mahata M, Pastinen T, Ehret GB, Schork NJ, Eskin E, Nievergelt CM, Saier MH, O'Connor DT. Genetic implication of a novel thiamine transporter in human hypertension. J Am Coll Cardiol. 2014 Apr 22; 63(15):1542-55. PMID: 24509276; PMCID: PMC3992204.
      17. Patrick K, Douglas Scutchfield F, Seidman CS, Waalen J. Moving on…. Am J Prev Med. 2013 Dec; 45(6):675-7. PMID: 24237908.
        View in: PubMed
      18. Rosenberg JD, Burian C, Waalen J, Saven A. Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series. Blood. 2014 Jan 09; 123(2):177-83. PMID: 24192579.
        View in: PubMed
      19. Waalen J. Avoiding errors in the medical literature: an editor's perspective. Am J Prev Med. 2013 Nov; 45(5):672-3. PMID: 24139783.
        View in: PubMed
      20. Zhang K, Deacon DC, Rao F, Schork AJ, Fung MM, Waalen J, Schork NJ, Nievergelt CM, Chi NC, O'Connor DT. Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected]. J Am Coll Cardiol. 2014 Feb 04; 63(4):358-68. PMID: 24140660; PMCID: PMC3946708.
      21. von Drygalski A, Kolaitis NA, Bettencourt R, Bergstrom J, Kruse-Jarres R, Quon DV, Wassel C, Li MC, Waalen J, Elias DJ, Mosnier LO, Allison M. Prevalence and risk factors for hypertension in hemophilia. Hypertension. 2013 Jul; 62(1):209-15. PMID: 23630949; PMCID: PMC3850775.
      22. Struss AK, Nunes A, Waalen J, Lowery CA, Pullanikat P, Denery JR, Conrad DJ, Kaufmann GF, Janda KD. Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states. Anal Chem. 2013 Mar 19; 85(6):3355-62. PMID: 23391272; PMCID: PMC3604138.
      23. Mbewe-Campbell N, Wei Z, Zhang K, Friese RS, Mahata M, Schork AJ, Rao F, Chiron S, Biswas N, Kim HS, Mahata SK, Waalen J, Nievergelt CM, Hook VY, O'Connor DT. Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure. J Hypertens. 2012 Oct; 30(10):1961-9. PMID: 22871890; PMCID: PMC3478326.
      24. Zhang K, Rao F, Miramontes-Gonzalez JP, Hightower CM, Vaught B, Chen Y, Greenwood TA, Schork AJ, Wang L, Mahata M, Stridsberg M, Khandrika S, Biswas N, Fung MM, Waalen J, Middelberg RP, Heath AC, Montgomery GW, Martin NG, Whitfield JB, Baker DG, Schork NJ, Nievergelt CM, O'Connor DT. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses. J Am Coll Cardiol. 2012 Oct 23; 60(17):1678-89. PMID: 23021333; PMCID: PMC3687554.
      25. Vosganian GS, Waalen J, Kim K, Jhatakia S, Schram E, Lee T, Riddell D, Mason JR. Effects of long-term cryopreservation on peripheral blood progenitor cells. Cytotherapy. 2012 Nov; 14(10):1228-34. PMID: 22900962.
        View in: PubMed
      26. Woolpert T, Brodine S, Lemus H, Waalen J, Blair P, Faix D. Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis. BMC Infect Dis. 2012 Jun 07; 12:129. PMID: 22676850; PMCID: PMC3407722.
      27. Friese RS, Ye C, Nievergelt CM, Schork AJ, Mahapatra NR, Rao F, Napolitan PS, Waalen J, Ehret GB, Munroe PB, Schmid-Schönbein GW, Eskin E, O'Connor DT. Integrated computational and experimental analysis of the neuroendocrine transcriptome in genetic hypertension identifies novel control points for the cardiometabolic syndrome. Circ Cardiovasc Genet. 2012 Aug 01; 5(4):430-40. PMID: 22670052; PMCID: PMC3467001.
      28. Koo D, Felix K, Dankwa-Mullan I, Miller T, Waalen J. A call for action on primary care and public health integration. Am J Public Health. 2012 Jun; 102 Suppl 3:S307-9. PMID: 22690962; PMCID: PMC3478083.
      29. Koo D, Felix K, Dankwa-Mullan I, Miller T, Waalen J. A call for action on primary care and public health integration. Am J Prev Med. 2012 Jun; 42(6 Suppl 2):S89-91. PMID: 22704438.
        View in: PubMed
      30. Waalen J. High points and hurdles in the translation of genomics. Transl Res. 2012 Feb; 159(2):61-3. PMID: 22243790.
        View in: PubMed
      31. Rao F, Chiron S, Wei Z, Fung MM, Chen Y, Wen G, Khandrika S, Ziegler MG, Benyamin B, Montgomery G, Whitfield JB, Martin NG, Waalen J, Hamilton BA, Mahata SK, O'Connor DT. Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins. Am J Hypertens. 2012 Jan; 25(1):29-40. PMID: 21918574; PMCID: PMC3664223.
      32. Waalen J, von Löhneysen K, Lee P, Xu X, Friedman JS. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol. 2011 Aug; 87(2):107-16. PMID: 21535154.
        View in: PubMed
      33. Waalen J, Buxbaum JN. Is older colder or colder older? The association of age with body temperature in 18,630 individuals. J Gerontol A Biol Sci Med Sci. 2011 May; 66(5):487-92. PMID: 21324956; PMCID: PMC3107024.
      34. Chen Y, Salem RM, Rao F, Fung MM, Bhatnagar V, Pandey B, Mahata M, Waalen J, Nievergelt CM, Lipkowitz MS, Hamilton BA, Mahata SK, O'Connor DT. Common charge-shift mutation Glu65Lys in K+ channel ß1-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease. Am J Nephrol. 2010; 32(5):414-24. PMID: 20861615; PMCID: PMC2975731.
      35. Chen Y, Zhang K, Wen G, Rao F, Sanchez AP, Wang L, Rodriguez-Flores JL, Mahata M, Mahata SK, Waalen J, Ziegler MG, Hamilton BA, O'Connor DT. Human dopamine ß-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure. Am J Hypertens. 2011 Jan; 24(1):24-32. PMID: 20814407; PMCID: PMC4906639.
      36. Waalen J. Current and emerging therapies for the treatment of osteoporosis. J Exp Pharmacol. 2010; 2:121-34. PMID: 27186098; PMCID: PMC4863293.
      37. Waalen J. More pieces to the iron chelation puzzle. Transl Res. 2010 Aug; 156(2):53-4. PMID: 20627189; PMCID: PMC2949416.
      38. Zhang K, Rao F, Wang L, Rana BK, Ghosh S, Mahata M, Salem RM, Rodriguez-Flores JL, Fung MM, Waalen J, Tayo B, Taupenot L, Mahata SK, O'Connor DT. Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension. J Am Coll Cardiol. 2010 Apr 06; 55(14):1463-75. PMID: 20359597; PMCID: PMC2889490.
      39. Sipe JC, Scott TM, Murray S, Harismendy O, Simon GM, Cravatt BF, Waalen J. Biomarkers of endocannabinoid system activation in severe obesity. PLoS One. 2010 Jan 20; 5(1):e8792. PMID: 20098695; PMCID: PMC2808340.
      40. Wang L, Rao F, Zhang K, Mahata M, Rodriguez-Flores JL, Fung MM, Waalen J, Cockburn MG, Hamilton BA, Mahata SK, O'Connor DT. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol. 2009 Sep 01; 54(10):944-54. PMID: 19712806; PMCID: PMC2792636.
      41. Fung MM, Rana BK, Tang CM, Shiina T, Nievergelt CM, Rao F, Salem RM, Waalen J, Ziegler MG, Insel PA, O'Connor DT. Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traits. Kidney Int. 2009 Nov; 76(10):1070-80. PMID: 19675531; PMCID: PMC2803094.
      42. Waalen J, Bruning AL, Peters MJ, Blau EM. A telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trial. Am J Manag Care. 2009 Aug 01; 15(8):e60-70. PMID: 19659407.
        View in: PubMed
      43. Waalen J, Beutler E. Genetic screening for low-penetrance variants in protein-coding genes. Annu Rev Genomics Hum Genet. 2009; 10:431-50. PMID: 19715441.
        View in: PubMed
      44. van der A DL, Rovers MM, Grobbee DE, Marx JJ, Waalen J, Ellervik C, Nordestgaard BG, Olynyk JK, Mills PR, Shepherd J, Grandchamp B, Boer JM, Caruso C, Arca M, Meyer BJ, van der Schouw YT. Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects. Circ Cardiovasc Genet. 2008 Oct; 1(1):43-50. PMID: 20031541.
        View in: PubMed
      45. Lee P, Gelbart T, Waalen J, Beutler E. The anemia of ageing is not associated with increased plasma hepcidin levels. Blood Cells Mol Dis. 2008 Nov-Dec; 41(3):252-4. PMID: 18676162.
        View in: PubMed
      46. Waalen J, Beutler E. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008 May 22; 358(21):2293-4; author reply 2294-5. PMID: 18499578.
        View in: PubMed
      47. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood. 2008 Apr 01; 111(7):3373-6. PMID: 18025154; PMCID: PMC2275006.
      48. Lee P, Waalen J, Crain K, Smargon A, Beutler E. Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. Blood Cells Mol Dis. 2007 Nov-Dec; 39(3):353-60. PMID: 17693102; PMCID: PMC2696477.
      49. Bartfai T, Waalen J, Buxbaum JN. Adipose tissue as a modulator of clinical inflammation: does obesity reduce the prevalence of rheumatoid arthritis? J Rheumatol. 2007 Mar; 34(3):488-92. PMID: 17309131.
        View in: PubMed
      50. Waalen J, Beutler E. Hereditary hemochromatosis: screening and management. Curr Hematol Rep. 2006 Mar; 5(1):34-40. PMID: 16537044.
        View in: PubMed
      51. Waalen J, Beutler E. Effect of correcting transferrin saturation for body mass index in HFE C282Y homozygotes. J Hepatol. 2006 Feb; 44(2):433-4; author reply 434-5. PMID: 16364490.
        View in: PubMed
      52. Waalen J, Beutler E. Beware of multiple comparisons: a study of symptoms associated with mutations of the HFE hemochromatosis gene. Clin Chim Acta. 2005 Nov; 361(1-2):128-34. PMID: 15993396.
        View in: PubMed
      53. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006 Mar 01; 107(5):1747-50. PMID: 16189263; PMCID: PMC1895695.
      54. Beutler E, Waalen J, Gelbart T. Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype. Blood Cells Mol Dis. 2005 Nov-Dec; 35(3):326-7. PMID: 16154780.
        View in: PubMed
      55. Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond). 2005 Jul; 29(7):755-9. PMID: 15809662.
        View in: PubMed
      56. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol. 2005 Jun; 18(2):203-20. PMID: 15737885.
        View in: PubMed
      57. Kim YH, Schiff E, Waalen J, Hovell M. Efficacy of acupuncture for treating cocaine addiction: a review paper. J Addict Dis. 2005; 24(4):115-32. PMID: 16368661.
        View in: PubMed
      58. Waalen J, Beutler E. No age-related decrease in frequency of heterozygotes for the HFE C282Y haemochromatosis mutation. J Hepatol. 2004 Jun; 40(6):1044; author reply 1044-5. PMID: 15158353.
        View in: PubMed
      59. Beutler E, Waalen J. Response to Moirand et al.-"HFE based re-evaluation of heterozygous hemochromatosis". Am J Med Genet A. 2004 Jan 15; 124A(2):218-9. PMID: 14699625.
        View in: PubMed
      60. Beutler E, Barton JC, Felitti VJ, Gelbart T, West C, Lee PL, Waalen J, Vulpe C. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis. 2003 Nov-Dec; 31(3):305-9. PMID: 14636643.
        View in: PubMed
      61. Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O'Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003 Jun; 9(6):1941-56. PMID: 12796356.
        View in: PubMed
      62. Beutler E, Waalen J, Felitti V. Screening strategies in C282Y-linked haemochromatosis. Br J Haematol. 2003 Mar; 120(6):1089-90. PMID: 12648083.
        View in: PubMed
      63. Beutler E, Felitti V, Gelbart T, Waalen J. Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry. Br J Haematol. 2003 Mar; 120(5):887-93. PMID: 12614226.
        View in: PubMed
      64. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Penetrance of hemochromatosis. Blood Cells Mol Dis. 2002 Nov-Dec; 29(3):418-32. PMID: 12678056.
        View in: PubMed
      65. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Am J Med. 2002 Oct 15; 113(6):472-9. PMID: 12427496.
        View in: PubMed
      66. Waalen J, Felitti V, Beutler E. Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ. 2002 Jul 20; 325(7356):137. PMID: 12130609; PMCID: PMC117231.
      67. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clin Proc. 2002 Jun; 77(6):522-30. PMID: 12059121.
        View in: PubMed
      68. Kim YH, Lichtenstein G, Waalen J. Distinguishing complementary medicine from alternative medicine. Arch Intern Med. 2002 Apr 22; 162(8):943; author reply 944. PMID: 11966347.
        View in: PubMed
      69. Waalen J, Felitti V, Beutler E. Metastatic carcinomatous cirrhosis and hepatic hemosiderosis. Arch Pathol Lab Med. 2002 Feb; 126(2):128. PMID: 11825105.
        View in: PubMed
      70. Waalen J, Beutler E. Comment on "Frequency of elevated serum transferrin saturation in elderly subjects". Clin Chim Acta. 2001 Apr; 306(1-2):145-8. PMID: 11370626.
        View in: PubMed
      71. Waalen J, Goodwin MM, Spitz AM, Petersen R, Saltzman LE. Screening for intimate partner violence by health care providers. Barriers and interventions. Am J Prev Med. 2000 Nov; 19(4):230-7. PMID: 11064226.
        View in: PubMed
      72. Pearlman DN, Waalen J. Violence against women: charting the impact on health policy, health care delivery, and the law. Am J Prev Med. 2000 Nov; 19(4):212-3. PMID: 11064222.
        View in: PubMed
      73. Hains F, Waalen J, Mior S. Psychometric properties of the neck disability index. J Manipulative Physiol Ther. 1998 Feb; 21(2):75-80. PMID: 9502061.
        View in: PubMed
      74. Borden EC, Waalen J, Schreiber R, Williams B. Response and resistance to interferons and interacting cytokines. J Natl Cancer Inst. 1995 Feb 15; 87(4):257-64. PMID: 7535860.
        View in: PubMed
      75. Borden EC, Waalen J, Liberati AM, Grignani F. Molecular diagnosis and monitoring of leukemia and lymphoma. Leuk Res. 1993 Dec; 17(12):1073-8. PMID: 8246612.
        View in: PubMed